Crosstalk of SOX2 and epithelial-to-mesenchymal transition on EGFR-TKI resistance

被引：0
|
作者：
Lee, An-Chun
Chiu, Yu-Fan
Kuo, Ming-Han
Wang, Yuan-Hung
Chou, Yu-Ting
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4155
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4155
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EGFR and SOX2 crosstalk determines EGFR-TKI
    Lee, An-Chun
    Yu, Chia-Cherng
    Wang, Yuan-Hung
    Chou, Yu-Ting
    CANCER RESEARCH, 2018, 78 (13)
  • [2] The emerging role of SOX2 in cancer cell plasticity and EGFR-TKI resistance
    Chiu, Yu-Fan
    Kuo, Ming-Han
    Lee, An-Chun
    Chou, Yu-Ting
    CANCER RESEARCH, 2016, 76
  • [3] Epithelial-Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
    Uramoto, Hidetaka
    Iwata, Teruo
    Onitsuka, Takamitsu
    Shimokawa, Hidehiko
    Hanagiri, Takeshi
    Oyama, Tsunehiro
    ANTICANCER RESEARCH, 2010, 30 (07) : 2513 - 2517
  • [4] Neuropilin-2 Promotes Acquired Resistance to EGFR-TKI Associated with the Epithelial-Mesenchymal Transition in Lung Cancer
    Nasarre, Patrick
    Nair-Menon, Joyce
    Dimou, Anastasios
    Yoshida, Takeshi
    Uramoto, Hidetaka
    Haura, Eric
    Gemmill, Robert M.
    Drabkin, Harry A.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S297 - S297
  • [5] Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells
    Clement, Michelle Simone
    Gammelgaard, Kristine Raaby
    Nielsen, Anders Lade
    Sorensen, Boe Sandahl
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) : 1904 - +
  • [6] The regulatory role of APE1 in epithelial-to-mesenchymal transition and in determining EGFR-TKI responsiveness in non-small-cell lung cancer
    Yang, Xiao
    Peng, Yu
    Jiang, Xuan
    Lu, Xianfeng
    Duan, Wei
    Zhang, Shiheng
    Dai, Nan
    Shan, Jinlu
    Feng, Yan
    Li, Xuemei
    Cheng, Yi
    Yang, Yuxin
    Baugh, Laura
    Tell, Gianluca
    Wang, Dong
    Li, Mengxia
    CANCER MEDICINE, 2018, 7 (09): : 4406 - 4419
  • [7] PrP© controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up
    Lailler, Claire
    Didelot, Audrey
    Garinet, Simon
    Berthou, Hugo
    Sroussi, Marine
    de Reynies, Aurelien
    Dedhar, Shoukat
    Martin-Lanneree, Severine
    Fabre, Elizabeth
    Le Pimpec-Barthes, Francoise
    Perrier, Alexandre
    Poindessous, Virginie
    Mansuet-Lupo, Audrey
    Djouadi, Fatima
    Launay, Jean-Marie
    Laurent-Puig, Pierre
    Blons, Helene
    Mouillet-Richard, Sophie
    ONCOGENE, 2024, 43 (37) : 2781 - 2794
  • [8] Epithelial-mesenchymal transition is associated with osteopontin-induced EGFR-TKI resistance in EGFR mutant non-small cell lung cancer
    Chen, Junjie
    Shi, Lin
    Qian, Yao
    Jin, Yi
    Dong, Nian
    Chen, Chengshui
    Wang, Beibei
    JOURNAL OF THORACIC DISEASE, 2023, 15 (06) : 3359 - +
  • [9] SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/β-catenin signal network
    Li, Xuefei
    Xu, Yingxi
    Chen, Yanan
    Chen, Si
    Jia, Xianpei
    Sun, Tongchao
    Liu, Yanhua
    Li, Xiru
    Xiang, Rong
    Li, Na
    CANCER LETTERS, 2013, 336 (02) : 379 - 389
  • [10] Management of patients with resistance to EGFR-TKI
    Barlesi, F.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2011, 67 : S30 - S35
12345